Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",16360,194,1.42 [1.12-1.80],0.0036964137960717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,16601,200,1.81 [1.38-2.36],1.508160207837405e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,16758,201,3.77 [2.74-5.20],4.903397276279124e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,14481,173,1.92 [1.22-3.03],0.0048697101068882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,14542,174,0.61 [0.42-0.88],0.0081533126805556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,14481,173,1.90 [1.51-2.40],5.7842791851155946e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,16811,204,1.77 [1.25-2.50],0.0012866768835286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,16360,194,1.30 [1.09-1.56],0.0043200224237892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,16816,200,1.52 [1.11-2.09],0.0094678664552381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,16586,198,1.38 [1.09-1.76],0.0083121359356506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,14569,173,0.44 [0.24-0.79],0.006573493259928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,14182,168,0.51 [0.37-0.71],5.163199634791074e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,14542,173,0.45 [0.29-0.68],0.0001998424765594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,16727,202,0.46 [0.30-0.71],0.0004089725962143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,16586,198,1.46 [1.10-1.93],0.0081354888374071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,14569,173,1.70 [1.39-2.08],1.7142978861803488e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",16732,202,2.00 [1.29-3.11],0.0019054544555248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,14530,173,1.26 [1.07-1.50],0.0069686565311985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,14481,173,1.83 [1.61-2.08],1.3655681645840373e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,14121,171,1.94 [1.56-2.42],2.9631222804134623e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,16732,202,2.07 [1.35-3.19],0.0009341854998852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,16627,201,1.77 [1.34-2.33],5.008785651796174e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,16753,201,3.30 [2.03-5.38],1.5147679557197688e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,14538,173,3.90 [1.80-8.45],0.0005552038832117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2,Complement C2,16727,202,0.49 [0.32-0.75],0.000980323740356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,14561,174,1.51 [1.14-1.99],0.0042065421052801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,16629,204,0.75 [0.62-0.91],0.0043512609895034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,16589,199,4.26 [2.32-7.82],2.958175545206989e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,16658,201,1.73 [1.34-2.24],2.799056154241052e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,16871,204,1.50 [1.16-1.95],0.0023325636292038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,16456,199,1.25 [1.07-1.46],0.0046457943374035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,16732,202,1.65 [1.36-2.01],6.5450036417389e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,16517,201,1.36 [1.09-1.70],0.0071232955186412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,16706,201,1.25 [1.08-1.45],0.0030885218226818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,16627,201,1.43 [1.27-1.61],4.0850041632747e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,16694,202,1.29 [1.13-1.46],9.54740106683023e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,16627,201,1.28 [1.07-1.53],0.0077865306641617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,16788,200,1.51 [1.23-1.86],0.0001065134808677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,16831,201,1.65 [1.29-2.11],6.499527577477855e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,16758,203,1.50 [1.14-1.99],0.0042928486930611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,16727,202,3.78 [2.27-6.31],3.293667686201376e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,16627,201,2.31 [1.50-3.55],0.0001319397183638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,16574,201,2.04 [1.47-2.84],2.2065821898877407e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,16831,201,3.32 [2.76-3.98],2.0905706846955422e-37
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,16727,202,3.61 [2.87-4.54],7.326244913984352e-28
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,16516,197,1.94 [1.42-2.64],2.5825954250059034e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,16314,196,2.30 [1.97-2.69],1.8330523143955072e-25
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,16791,202,1.74 [1.24-2.45],0.0014924626641074
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,16757,199,1.75 [1.32-2.32],9.726965965087688e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,16816,200,1.65 [1.30-2.10],4.428961280955414e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,16586,198,1.83 [1.26-2.67],0.0015842350854514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,16597,201,1.74 [1.35-2.24],1.6352958253339778e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,16706,201,3.98 [2.71-5.84],1.868783218416418e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,16788,200,3.60 [2.90-4.47],7.0192946664910255e-31
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,14493,172,1.97 [1.46-2.66],9.503140396038064e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,16806,201,1.72 [1.36-2.19],7.727394252493364e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,14089,171,1.95 [1.53-2.49],6.113974979785996e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,16627,201,3.26 [2.57-4.13],1.3137629962207633e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,14257,171,4.78 [3.82-5.98],1.882998544852697e-42
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,16791,202,2.97 [2.18-4.04],4.545667006851076e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,16831,201,3.88 [3.27-4.61],9.084364761992243e-54
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,14542,174,6.70 [4.95-9.06],4.963701942917293e-35
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,16627,201,4.47 [3.34-5.98],5.7170378671943896e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,14481,173,3.29 [2.14-5.06],5.694076484765094e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,16791,202,1.89 [1.39-2.56],4.76512912036526e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,16627,201,1.42 [1.24-1.62],2.834324006281565e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,16368,194,1.22 [1.06-1.42],0.0069756059066446
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,16720,203,0.81 [0.69-0.95],0.009980262827313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,16586,198,0.65 [0.52-0.80],8.199988789044336e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",14530,173,1.70 [1.27-2.27],0.0003552716452753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,14556,175,1.20 [1.06-1.37],0.0055945093223639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,14167,166,1.54 [1.20-1.98],0.0007044952091149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,16768,201,2.04 [1.47-2.84],2.277125822063776e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,14556,175,1.58 [1.24-2.01],0.0002429474826954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,14121,171,2.85 [1.77-4.61],1.8323046210288e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,16627,201,1.48 [1.15-1.91],0.0025688148503485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,16627,201,1.76 [1.22-2.55],0.0026866720486411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,16314,196,1.86 [1.47-2.34],1.7510919775657534e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,16831,201,1.46 [1.12-1.90],0.0047879701510917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,14530,173,3.03 [2.18-4.20],3.061684316540919e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,16682,204,0.53 [0.35-0.78],0.0015289596133208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,14508,173,2.72 [1.86-3.98],2.493933210786604e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,16758,203,2.71 [2.12-3.46],1.286480942079027e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,16871,204,0.60 [0.40-0.88],0.0096975562700228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,16516,197,3.05 [2.44-3.81],1.7974154097790787e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,16732,202,2.40 [1.56-3.67],5.9670620737994646e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,14561,174,1.84 [1.31-2.58],0.0004262186357176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,14121,171,2.07 [1.44-2.97],8.238483054108334e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,16731,203,1.78 [1.19-2.68],0.00540389586198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,13039,156,2.29 [1.24-4.25],0.0084853218601729
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,16791,202,1.27 [1.12-1.45],0.0002514648752404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,16791,202,1.62 [1.50-1.75],3.5508070320971885e-33
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,16851,204,0.44 [0.26-0.75],0.0024369252975679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,16732,202,1.66 [1.44-1.92],3.560867772698836e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,14556,175,0.46 [0.26-0.82],0.0089187934355163
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,16650,200,2.71 [1.87-3.92],1.203723006138499e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,16443,197,1.12 [1.03-1.22],0.0091396041146462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,16727,202,2.30 [1.57-3.37],2.0009031306467165e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,16407,199,0.46 [0.30-0.73],0.0007701774057238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,16504,203,2.10 [1.53-2.89],5.006035403084279e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,16786,200,3.00 [2.04-4.39],1.8949596914568612e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,16816,200,1.62 [1.18-2.21],0.0025874107619745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,14121,171,1.41 [1.11-1.79],0.004953485062896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,16487,196,2.96 [2.12-4.13],2.0223551873028434e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,16314,196,1.64 [1.26-2.16],0.0003040016714102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,16871,204,0.36 [0.17-0.76],0.0078478640607554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,16084,194,1.90 [1.37-2.63],0.0001124965533843
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,16487,197,2.30 [1.58-3.35],1.3487062359591864e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,16627,201,1.43 [1.26-1.63],4.3548875465436754e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,16791,202,2.20 [1.38-3.52],0.0009748063953009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,16871,204,0.49 [0.31-0.76],0.001759950499925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,14542,174,1.97 [1.64-2.37],4.990225483845768e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,16682,204,2.40 [1.99-2.88],1.2473591620243207e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,16650,200,3.13 [2.56-3.84],5.1419773921159855e-28
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,16745,199,3.15 [2.75-3.61],4.969186754120332e-61
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,16368,194,2.58 [2.12-3.13],1.5729488881652613e-21
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,16682,204,1.57 [1.27-1.94],3.257265797234223e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,16314,196,1.46 [1.27-1.69],1.04214009804458e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,16727,202,0.53 [0.36-0.77],0.0008721202646186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,14556,175,0.63 [0.47-0.85],0.0026901333931066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,14182,168,1.48 [1.17-1.88],0.0009565576572976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,14182,168,2.46 [1.44-4.21],0.001032685967022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,16291,196,1.50 [1.12-1.99],0.0058209804685819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,16732,202,0.75 [0.61-0.91],0.0037227924247695
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,14080,168,0.60 [0.42-0.86],0.0050483675167113
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,14504,173,1.47 [1.20-1.79],0.0001769385301118
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",16586,198,2.72 [1.96-3.77],2.489473685918057e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,16871,204,1.42 [1.10-1.84],0.0073842121256506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,16601,200,3.29 [2.03-5.33],1.4214961254513888e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",16586,198,1.31 [1.07-1.60],0.008167739986574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,16831,201,2.14 [1.61-2.83],1.1607310094607296e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,16360,194,1.22 [1.07-1.39],0.003103155246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,16682,204,1.66 [1.19-2.31],0.0028542535322332
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,14424,173,0.63 [0.47-0.86],0.003573085446817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,14493,172,1.41 [1.09-1.82],0.008610885613305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",16582,201,1.68 [1.22-2.31],0.0015068987009992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",16627,201,2.60 [1.85-3.64],3.4936909176910565e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,16314,196,0.61 [0.43-0.86],0.0054362989586414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,16816,200,1.59 [1.23-2.05],0.0003370790918099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,16623,201,2.31 [1.55-3.46],4.3634550998249295e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,16871,204,2.15 [1.46-3.18],0.0001177937275634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,16871,204,5.63 [3.74-8.47],1.1599626684465754e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,14111,168,2.04 [1.47-2.83],1.832479200781921e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,16732,202,2.07 [1.21-3.56],0.0081754489732543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,16280,196,1.48 [1.16-1.91],0.0019836696930829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,16627,201,2.01 [1.64-2.45],9.262258717821856e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,16849,204,1.48 [1.20-1.82],0.0001998279352376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,14542,174,0.75 [0.63-0.91],0.0026635164837197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,16368,194,1.44 [1.31-1.59],6.62980465811632e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,16586,198,1.70 [1.48-1.95],4.5339063018335845e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,16831,201,2.11 [1.70-2.61],1.4371327621499912e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,16368,194,2.14 [1.60-2.86],3.306764719233129e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,16368,194,1.81 [1.26-2.58],0.0011637883485886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,16427,201,1.49 [1.18-1.88],0.0007687235798417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,16603,199,1.67 [1.31-2.13],3.568721813624252e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,16758,203,2.41 [1.70-3.41],6.596386335869396e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,16227,196,1.30 [1.10-1.52],0.0015951454681032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,14496,174,1.30 [1.07-1.56],0.0067931676246708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,16544,201,3.79 [2.98-4.83],3.826551971092418e-27
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,14496,174,1.45 [1.10-1.92],0.0086584395983865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,16368,194,1.68 [1.17-2.43],0.0053442547778493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,16627,201,2.15 [1.61-2.86],1.7639757309760784e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,16586,198,1.34 [1.19-1.51],2.161223584464295e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,14496,174,1.52 [1.18-1.96],0.0012363029249594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,16627,201,0.58 [0.40-0.84],0.0037118299976613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,14121,171,1.63 [1.14-2.33],0.0079185768486054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,16816,200,1.64 [1.28-2.09],7.863380405891445e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,16758,203,1.76 [1.25-2.46],0.0010781760728052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,16627,201,1.40 [1.14-1.70],0.0010333769384619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,16368,194,1.53 [1.26-1.85],1.4532045336292049e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,14265,169,1.59 [1.25-2.04],0.0002076215585421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,16280,196,1.48 [1.12-1.95],0.0052414900981778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,16831,201,2.19 [1.62-2.96],3.57186449913159e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,16831,201,1.50 [1.15-1.95],0.0025445272779726
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,14530,173,1.69 [1.32-2.16],3.1980552807056365e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,16586,198,2.17 [1.68-2.79],3.036538998840869e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,16652,201,1.99 [1.52-2.62],8.219576024026607e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,16516,197,1.27 [1.11-1.44],0.0003637586304316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,16668,201,1.97 [1.35-2.86],0.0004067627494125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,14080,168,1.35 [1.08-1.69],0.007415027291269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,16623,199,1.87 [1.27-2.76],0.0016828350095688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,16871,204,2.69 [1.71-4.23],1.7126886047656495e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,16368,194,1.94 [1.49-2.53],8.96586005325356e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,14530,173,2.51 [1.69-3.73],4.586000002346908e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,14569,173,2.66 [1.58-4.48],0.0002254586666313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,16758,200,1.88 [1.33-2.65],0.0003537387576155
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,16627,201,1.51 [1.12-2.03],0.0066773130064831
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,16627,201,2.24 [1.88-2.65],2.811052080888782e-20
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,16871,204,1.66 [1.13-2.42],0.0093580458014115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,16627,201,1.80 [1.28-2.53],0.0006577732664716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,16449,198,6.29 [4.37-9.04],3.12110819871572e-23
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,16314,196,1.55 [1.30-1.84],7.043872312647008e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,16452,196,1.35 [1.12-1.63],0.0018434890463652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",14182,168,2.65 [1.46-4.81],0.0013396505527861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,16650,200,2.57 [1.60-4.12],8.881172566942292e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,16368,194,1.39 [1.09-1.77],0.0078464280597037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,16682,200,1.55 [1.25-1.92],7.897912989313258e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,16314,196,1.58 [1.26-1.99],9.008389087408964e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",16280,196,1.98 [1.78-2.21],1.0460012634712514e-35
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,16871,204,3.14 [1.45-6.82],0.0038020257907624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,14307,171,2.04 [1.45-2.88],4.751103858889331e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,16627,201,1.64 [1.31-2.06],1.7273350799457136e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,14556,175,0.56 [0.36-0.87],0.0099184455905956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,16682,204,2.24 [1.53-3.28],3.590981236730301e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,16586,198,0.78 [0.64-0.94],0.0079949773947651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,14514,173,3.12 [1.62-6.04],0.0007096186175399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,16680,201,2.38 [1.65-3.44],3.324421205652598e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,16682,204,0.54 [0.34-0.86],0.009054899969766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,16627,201,1.28 [1.10-1.50],0.0016306001526609
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,16785,198,3.44 [3.04-3.89],2.1568157497929485e-85
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,16586,198,1.87 [1.29-2.71],0.0009792234260957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,16831,201,2.06 [1.33-3.19],0.0012140411515698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,14167,166,1.32 [1.11-1.57],0.0018743910983952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,16682,204,1.91 [1.28-2.84],0.001479808824272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,16833,204,0.69 [0.55-0.88],0.0026554489156907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,16560,200,2.00 [1.29-3.11],0.0019009634783453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,14121,171,1.49 [1.15-1.94],0.0024277190184839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",16586,198,1.47 [1.11-1.95],0.0068434712358529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,16314,196,1.25 [1.06-1.49],0.0098092651689698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,14416,172,1.74 [1.15-2.63],0.0083767773804877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,16568,200,1.81 [1.27-2.58],0.0010345422877418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,14556,175,5.88 [3.72-9.29],3.476231880436189e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,14569,173,1.45 [1.10-1.92],0.0091357354082487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,16725,203,1.89 [1.21-2.94],0.0051099863466484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,16586,198,1.39 [1.12-1.72],0.0025466686772992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,16577,200,1.46 [1.18-1.82],0.0005982769104522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,16871,204,1.35 [1.11-1.63],0.0021830490836364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,16871,204,1.31 [1.10-1.56],0.0027007541183784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,16682,204,2.34 [1.61-3.40],7.666629933122501e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,14452,173,1.71 [1.32-2.21],4.488744445764241e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,16806,204,2.48 [1.80-3.42],2.362422228962393e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,14182,168,2.31 [1.69-3.17],1.981212637877038e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,16680,201,3.25 [2.13-4.95],4.918849215551759e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,14182,168,1.62 [1.21-2.16],0.0011876976230442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,16314,196,1.52 [1.30-1.76],6.651722908520132e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,16208,194,1.79 [1.25-2.57],0.0015318730075219
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,14257,171,1.99 [1.54-2.57],1.33032196050332e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,14182,168,1.57 [1.18-2.10],0.0020660323756098
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,14569,173,4.89 [2.95-8.13],8.783193792369434e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,14257,171,1.86 [1.40-2.47],1.7024707729123985e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,16586,198,1.56 [1.13-2.17],0.0073061861840134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,16791,202,2.35 [1.54-3.58],6.745845256216612e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,16833,204,3.74 [2.92-4.78],1.098304285435873e-25
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,14510,172,2.54 [1.26-5.11],0.008873977900024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,14288,171,0.41 [0.23-0.74],0.003392822992354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,14340,172,0.47 [0.27-0.80],0.0059278375171934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,14569,173,2.72 [1.31-5.67],0.0073676199559135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,16498,197,1.81 [1.56-2.10],3.335289414736034e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,16627,201,1.36 [1.16-1.60],0.0002123040263342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,14556,175,2.15 [1.47-3.13],7.350811179089094e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,16732,202,1.61 [1.21-2.15],0.0011396128711282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,16627,201,5.30 [3.97-7.07],1.1097467707387168e-29
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,16816,200,3.84 [2.85-5.19],1.388520457300539e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,14182,168,2.00 [1.45-2.75],2.407153983676173e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,16635,201,1.77 [1.37-2.28],1.1459874687311614e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,16368,194,1.51 [1.21-1.88],0.0003017954807495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,16314,196,2.93 [2.26-3.79],3.3760626106596837e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,16314,196,1.87 [1.49-2.36],1.0115057870921305e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,16816,200,1.85 [1.35-2.53],0.0001129769708033
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,14481,173,1.33 [1.11-1.60],0.0016729282702078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',14530,173,1.32 [1.07-1.63],0.0088734085529929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,16682,204,1.51 [1.15-1.97],0.0027691655850673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,14257,171,1.89 [1.31-2.73],0.0006888929816817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,16791,202,1.95 [1.54-2.48],4.88382068467562e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,14481,173,1.91 [1.48-2.47],8.064055625571907e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,14542,174,2.38 [1.85-3.05],8.660258982498472e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,16684,202,1.40 [1.10-1.77],0.0056932634075506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,16627,201,1.47 [1.15-1.88],0.0023729799097571
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,16650,200,1.75 [1.20-2.56],0.0037811605380182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,14282,168,1.79 [1.52-2.11],5.674368092152055e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,16758,203,1.56 [1.18-2.07],0.001768364742405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,16522,198,1.77 [1.16-2.71],0.0077526973749071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,16758,203,1.70 [1.33-2.17],2.2989407155729528e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,16335,194,1.84 [1.57-2.14],1.2054136293928951e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,16516,197,2.13 [1.65-2.75],5.037536847060603e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,16516,197,1.42 [1.24-1.63],5.393617715453581e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,16831,201,1.58 [1.17-2.12],0.0025523413086187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,16680,201,3.96 [3.41-4.60],1.4588078325345858e-72
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,16368,194,4.70 [3.95-5.60],1.3340197848241851e-67
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,16680,201,1.80 [1.23-2.62],0.002495572815942
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,14257,171,2.46 [1.76-3.44],1.4330071321228428e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,16816,200,1.69 [1.18-2.40],0.0038350959685326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,16682,204,1.81 [1.25-2.62],0.0018150437269172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,16682,204,1.75 [1.48-2.06],4.494303203377696e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,16806,201,4.39 [3.49-5.53],1.1021819921205458e-36
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,16516,197,1.72 [1.45-2.04],2.7484076488198046e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,16791,202,2.77 [2.29-3.34],2.557673819691956e-26
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,16516,197,4.76 [4.07-5.55],6.095510995633263e-87
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,16627,201,1.43 [1.17-1.76],0.000616375926317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,14556,175,3.07 [2.31-4.08],9.294120342109067e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,16682,204,2.60 [1.84-3.67],6.520766948754597e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,16516,197,1.70 [1.25-2.31],0.0006551586118115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,14530,173,1.52 [1.14-2.02],0.0047963940318313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,16727,202,5.00 [3.47-7.20],6.721100677248783e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,14496,174,1.30 [1.07-1.59],0.0090723550534956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,16665,204,1.52 [1.14-2.02],0.0045004991272914
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,15845,189,1.58 [1.18-2.12],0.0021990660770895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,16816,200,1.45 [1.22-1.72],2.791264500849268e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,14121,171,1.55 [1.18-2.03],0.0016575443019827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,16360,194,1.41 [1.12-1.79],0.0040379267080197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,14530,173,1.71 [1.33-2.18],1.9710034919522463e-05
